-
Ferring demonstrates commitment to R&D investment through expanded Innovation Grants Program
in Uncategorized onThe Ferring Innovation Grants Program, which is now open for applications, has been significantly expanded as part of Ferring’s continued commitment to investing in research and development…
0 -
Ferring Pharmaceuticals and North Zealand University Hospital announce eHealth collaboration aimed at transforming IBD patient care
in Uncategorized onTo mark World IBD Day 2016, Ferring Pharmaceuticals and North Zealand University Hospital in Copenhagen…
-
Ferring Pharmaceuticals announces approval for NOCDURNA®, a new therapeutic option for the treatment of adults waking multiple times to urinate at night
in Uncategorized onFerring Pharmaceuticals today announced that NOCDURNA® (desmopressin) has received approval in the EU…
-
Newly created Swiss Polar Institute to launch a major Antarctic expedition
in Uncategorized onThe future of the Earth’s poles is critical. In the coming decades, major international negotiations will focus on the polar regions, which are bearing…
-
Wake up to nocturia: The most common cause of disrupted sleep that could be damaging your health
in Uncategorized onToday is ‘World Sleep Day’ which was initiated by the World Association of Sleep Medicine (WASM) to acknowledge the importance of a…
-
Ferring Pharmaceuticals opens Asia Pacific headquarters in Singapore
in Uncategorized onThe new Ferring Asia-Pacific Regional Headquarters focuses on supply chain planning and coordination to support the growth of emerging markets…
-
Healthcare Supply Chain Academy (HSCA) program launched by International Institute for the Management of Logistics (IML) in collaboration with Ferring Pharmaceuticals, Merck and Supply Chain Operations SA
in Uncategorized onIn collaboration with Ferring Pharmaceuticals, Merck and Supply Chain Operations SA…
-
Ferring announces the start of the PRONOUNCE Trial for patients with advanced prostate cancer and cardiovascular disease receiving degarelix or leuprolide
in Uncategorized onFerring Pharmaceuticals announced today the commencement of the Phase 3b PRONOUNCE Trial. The trial will compare the occurrence of major…
-
Ferring Pharmaceuticals and Karolinska Institutet sign collaboration agreement on the development of a Human Microbiome Translational Research Programme
in Uncategorized onFerring Pharmaceuticals and Karolinska Institutet announce today that a collaboration agreement has been signed for the establishment of a…
-
Targeted Immuno Therapies AB and Ferring Pharmaceuticals sign a strategic collaboration agreement for the treatment of IBD
in Uncategorized onTargeted Immuno Therapies (TLA) announced today that it has signed a strategic collaboration agreement with Ferring Pharmaceuticals…
Uncategorized
Uncategorized